Dear Sir/Madam, Pursuant to Regulation 57(4) of SEBI (LODR) Regulations, 2015 please find the attached intimation. You are requested to take the same on record and oblige. Thanking You.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy Ltd has informed the stock exchanges that it has not issued any non-convertible securities (such as NCDs, bonds, or preference shares) for which any interest, dividend, or principal repayment falls due during the quarter from 1 July 2025 to 30 September 2025. The filing is a routine compliance submission under Regulation 57(4) of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, and has been signed by Director Davender Singh (DIN: 09447213). Essentially, the company is confirming a 'nil' obligation for the upcoming quarter. No financial details, amounts, or triggers are disclosed because none are applicable.
This is a routine, non-event filing with no material impact on shareholders or stock price. It simply confirms that Prism Medico has no debt-servicing or preference-dividend obligations in Q2 FY26, which is a neutral compliance update.